A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
Clinical trial NCT04605159 · TERMINATED
Trial details
- NCT number
- NCT04605159
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2023-06-14
- Enrollment
- 11194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.